Reproductive BioMedicine Online
Volume 20, Issue 4 , Pages 504-509 , April 2010

Double measurements of serum HCG concentration and its ratio may predict IVF outcome

Received 27 April 2009 ,Revised 28 May 2009 ,Accepted 3 December 2009.

References 

  1. Barrenetxea G, Barinaga-Rementeria L, Lopez de Larruzea A, et al. Heterotopic pregnancy: two cases and a comparative review. Fertil. Steri. 2007;87:417–419415
  2. Bergh T, Ericson A, Hillensjo T, et al. Deliveries and children born after in-vitro fertilisation in Sweden 1982–95: a retrospective cohort study. Lancet. 1999;354:1579–1585
  3. Bjercke S, Tanbo T, Dale PO, et al. Human chorionic gonadotrophin concentrations in early pregnancy after in-vitro fertilization. Hum. Reprod. 1999;14:1642–1646
  4. Check JH, Weiss RM, Lurie D. Analysis of serum human chorionic gonadotrophin levels in normal singleton, multiple and abnormal pregnancies. Hum. Reprod. 1992;7:1176–1180
  5. Chen CD, Ho HN, Wu MY, et al. Paired human chorionic gonadotrophin determinations for the prediction of pregnancy outcome in assisted reproduction. Hum. Reprod. 1997;12:2538–2541
  6. Chin HY, Chen FP, Wang CJ, et al. Heterotopic pregnancy after in vitro fertilization-embryo transfer. Int. J. Gynaecol. Obstet. 2004;86:411–416
  7. Glatstein IZ, Hornstein MD, Kahana MJ, et al. The predictive value of discriminatory human chorionic gonadotropin levels in the diagnosis of implantation outcome in in vitro fertilization cycles. Fertil. Steril. 1995;63:350–356
  8. Homan G, Brown S, Moran J, et al. Human chorionic gonadotropin as a predictor of outcome in assisted reproductive technology pregnancies. Fertil. Steril. 2000;73:270–274
  9. Inion I, Gerris J, Joostens M, et al. An unexpected triplet heterotopic pregnancy after replacement of two embryos. Hum. Reprod. 1998;13:1999–2001
  10. Korhonen J, Tiitinen A, Alfthan H, et al. Ectopic pregnancy after in-vitro fertilization is characterized by delayed implantation but a normal increase of serum human chorionic gonadotrophin and its subunits. Hum. Reprod. 1996;11:2750–2757
  11. Legro RS, Paulson RJ, Lobo RA, et al. Association of early beta-human chorionic gonadotrophin values with pregnancy wastage and multiple implantation in a donor oocyte programme. Hum. Reprod. 1995;10:3293–3296
  12. Macklon NS, Geraedts JP, Fauser BC. Conception to ongoing pregnancy: the ‘black box’ of early pregnancy loss. Hum. Reprod. Update. 2002;8:333–343
  13. Marcus SF, Brinsden PR. Analysis of the incidence and risk factors associated with ectopic pregnancy following in-vitro fertilization and embryo transfer. Hum. Reprod. 1995;10:199–203
  14. Poikkeus P, Hiilesmaa V, Tiitinen A. Serum HCG 12 days after embryo transfer in predicting pregnancy outcome. Hum. Reprod. 2002;17:1901–1905
  15. Porat S, Savchev S, Bdolah Y, et al. Early serum beta-human chorionic gonadotropin in pregnancies after in vitro fertilization: contribution of treatment variables and prediction of long-term pregnancy outcome. Fertil. Steril. 2007;88:82–89
  16. Strandell A, Thorburn J, Hamberger L. Risk factors for ectopic pregnancy in assisted reproduction. Fertil. Steril. 1999;71:282–286
  17. Sugantha SE, Webster S, Sundar E, et al. Predictive value of plasma human chorionic gonadotrophin following assisted conception treatment. Hum. Reprod. 2000;15:469–473
  18. Tal J, Haddad S, Gordon N, et al. Heterotopic pregnancy after ovulation induction and assisted reproductive technologies: a literature review from 1971 to 1993. Fertil. Steril. 1996;66:1–12
  19. Urbancsek J, Hauzman E, Fedorcsak P, et al. Serum human chorionic gonadotropin measurements may predict pregnancy outcome and multiple gestation after in vitro fertilization. Fertil. Steril. 2002;78:540–542

 Hongbin Chi received her MD in 2006 from the Shanghai Jiao Tong University in China. She is an Associate Professor and works at the Medical Center for Human Reproduction, Department of Obstetrics and Gynaecology, Peking University Third Hospital, Beijing. She has a particular interest in reproductive hormone testing for predicting the outcomes of assisted reproductive technology. She specializes in diagnoses and management of infertility and reproductive endocrine diseases.

PII: S1472-6483(10)00006-4

doi: 10.1016/j.rbmo.2010.01.005

Reproductive BioMedicine Online
Volume 20, Issue 4 , Pages 504-509 , April 2010